CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 196 filers reported holding CYTOKINETICS INC in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $864,171 | -22.9% | 15,950 | -0.2% | 0.04% | -2.7% |
| Q1 2024 | $1,120,708 | -21.6% | 15,985 | -6.6% | 0.04% | -46.4% |
| Q4 2023 | $1,429,432 | +163.5% | 17,121 | -7.0% | 0.07% | +146.4% |
| Q3 2023 | $542,535 | -17.8% | 18,416 | -9.0% | 0.03% | -15.2% |
| Q2 2023 | $660,392 | -5.9% | 20,245 | +1.5% | 0.03% | -8.3% |
| Q1 2023 | $702,041 | -17.6% | 19,950 | +7.3% | 0.04% | -20.0% |
| Q4 2022 | $852,298 | +12.7% | 18,601 | +19.2% | 0.04% | +4.7% |
| Q3 2022 | $756,000 | +21.7% | 15,607 | -1.3% | 0.04% | +38.7% |
| Q2 2022 | $621,000 | -2.8% | 15,818 | -8.8% | 0.03% | +6.9% |
| Q1 2022 | $639,000 | -16.9% | 17,351 | +2.9% | 0.03% | -12.1% |
| Q4 2021 | $769,000 | +11.3% | 16,862 | -12.8% | 0.03% | +6.5% |
| Q3 2021 | $691,000 | +38.5% | 19,345 | -23.3% | 0.03% | +40.9% |
| Q2 2021 | $499,000 | -15.3% | 25,211 | -0.4% | 0.02% | -18.5% |
| Q1 2021 | $589,000 | – | 25,322 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,721,888 | $46,633,000 | 5.62% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 107,139 | $873,000 | 0.62% |
| Virtus ETF Advisers LLC | 42,645 | $348,000 | 0.44% |
| SPHERA FUNDS MANAGEMENT LTD. | 210,000 | $1,712,000 | 0.20% |
| LANSDOWNE PARTNERS (UK) LLP | 2,647,981 | $21,581,000 | 0.20% |
| WASATCH ADVISORS LP | 1,679,778 | $13,690,000 | 0.18% |
| PINNACLE ASSOCIATES LTD | 877,575 | $7,152,000 | 0.14% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 107,728 | $878,000 | 0.12% |
| Tekla Capital Management LLC | 350,300 | $2,855,000 | 0.11% |
| Financial Gravity Companies, Inc. | 9,302 | $86,000 | 0.10% |